A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma

胶质母细胞瘤患者来源细胞系和异种移植模型参考库,包括前神经型、经典型和间充质型胶质母细胞瘤。

阅读:4
作者:Brett W Stringer ,Bryan W Day ,Rochelle C J D'Souza ,Paul R Jamieson ,Kathleen S Ensbey ,Zara C Bruce ,Yi Chieh Lim ,Kate Goasdoué ,Carolin Offenhäuser ,Seçkin Akgül ,Suzanne Allan ,Thomas Robertson ,Peter Lucas ,Gert Tollesson ,Scott Campbell ,Craig Winter ,Hongdo Do ,Alexander Dobrovic ,Po-Ling Inglis ,Rosalind L Jeffree ,Terrance G Johns ,Andrew W Boyd

Abstract

Low-passage, serum-free cell lines cultured from patient tumour tissue are the gold-standard for preclinical studies and cellular investigations of glioblastoma (GBM) biology, yet entrenched, poorly-representative cell line models are still widely used, compromising the significance of much GBM research. We submit that greater adoption of these critical resources will be promoted by the provision of a suitably-sized, meaningfully-described reference collection along with appropriate tools for working with them. Consequently, we present a curated panel of 12 readily-usable, genetically-diverse, tumourigenic, patient-derived, low-passage, serum-free cell lines representing the spectrum of molecular subtypes of IDH-wildtype GBM along with their detailed phenotypic characterisation plus a bespoke set of lentiviral plasmids for bioluminescent/fluorescent labelling, gene expression and CRISPR/Cas9-mediated gene inactivation. The cell lines and all accompanying data are readily-accessible via a single website, Q-Cell (qimrberghofer.edu.au/q-cell/) and all plasmids are available from Addgene. These resources should prove valuable to investigators seeking readily-usable, well-characterised, clinically-relevant, gold-standard models of GBM.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。